Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes.
about
New aspects of influenza viruses.Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.Response to influenza infection in mice with a targeted disruption in the interferon gamma geneFunctional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen.HLA-B37 and HLA-A2.1 molecules bind largely nonoverlapping sets of peptidesIdentification of residues necessary for clonally specific recognition of a cytotoxic T cell determinant.Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes.Periodic variation in side-chain polarities of T-cell antigenic peptides correlates with their structure and activityInfluence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation.Effect of MHC class I diversification on influenza epitope-specific CD8+ T cell precursor frequency and subsequent effector function.Theoretical and practical aspects of antigenized antibodies.Specificity of the H-2 L(d)-restricted cytotoxic T-lymphocyte response to the mouse hepatitis virus nucleocapsid proteinA sequence pattern common to T cell epitopesCytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition.Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen.Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.T cell memory. Long-term persistence of virus-specific cytotoxic T cells.Identical peptides recognized by MHC class I- and II-restricted T cells.Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptidesPresentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectantBone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunityCharacterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein.Comparative analysis of core amino acid residues of H-2D(b)-restricted cytotoxic T-lymphocyte recognition epitopes in simian virus 40 T antigenImmune regulation in Epstein-Barr virus-associated diseasesPresentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule.Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutininCharacterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutininDissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants.The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus.Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research CenterRevival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development.Immunological control of ticks and tick-borne parasitic diseases of livestock.Cytotoxic T cells in influenza infection.Polymorphism of cytotoxic T-lymphocyte clones that recognize a defined nine-amino-acid immunodominant domain of lymphocytic choriomeningitis virus glycoprotein.High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance.Antigenicity and immunogenicity of antigenized antibodies. Studies on B and T cells.Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum.
P2860
Q30333613-BC5BAC5F-56A8-473D-AD41-1CB50F97FABCQ30442735-1888695B-C8B7-4A04-9B9A-B11B374787FCQ30442876-CBA6FADF-1F77-473E-83FA-9C61E956BF84Q30452642-6F613FF0-FAD3-4672-8E2E-9CDC00290508Q33563433-54A2E1DE-A374-4AA3-90F2-46BDAFE8A729Q33572540-6DB62A63-7A4A-4434-82F0-BB2C9CAE4907Q33835879-2EE4A676-0DDB-456E-9B9E-F0A748B2223FQ33973345-A0D40308-9CA1-4AA9-9C04-F289BE4C677DQ34632481-B2E1CD50-07D8-4162-8E44-16B9F881553DQ35012614-3B885385-D9C7-4C53-8D0D-A669988AB3E9Q35180010-7471DFAA-428C-4C7B-A024-C5772E1E51D3Q35860625-5623E251-0484-4CBC-8AB9-9C55E6C10E68Q35973055-9D65283B-8D0C-4233-9BE0-6D8AA497D6A2Q36230704-7EA49AD8-2F53-4FBA-A3B7-8982F4865FCBQ36231571-D1DC2FA0-10B6-4029-B5BB-712B2824BAE2Q36355057-49431408-E13A-4623-8D5D-C43CC25462F1Q36355512-D8CE219C-88E7-48BE-A80B-B517CA0CDD2BQ36356494-51A5470B-F53E-42CF-9927-E9081870E0C7Q36356596-64503C17-4E4B-43CA-823B-70ED19785461Q36357631-653F4123-DE04-4F56-A3DA-AFDAAAA3F77DQ36364290-45F6FB42-1076-4910-A0BF-82FF085C41EAQ36365159-3AC2234C-5DE3-4866-814C-50E4A1A6B8A8Q36366051-C46712EA-CDB4-4CEF-AFDE-98D579DE18C7Q36654927-202C8B9A-3210-4C6A-8336-1834DA86501BQ36656271-D937AB5E-76A0-4BBB-ADFC-5C9CE698E0A7Q36669953-A3FF9058-8FC5-4C91-A796-CEC89C0CA4CBQ36780717-99C93F13-101E-4D47-9C09-62084D2A8556Q36796317-E06AD12E-04C2-42A4-BC45-90AF99D630F7Q36798170-84AEFE68-9E22-4019-83D8-0D618CA39620Q36802213-873F20C2-DB31-4C92-8D11-C85F949D1383Q36803727-285C70EC-4AB7-41E7-8ED1-15D1C2DF1E79Q36875351-74F317B5-88EB-4273-8465-8FC8D2F264C8Q37358369-798443FE-2075-474F-B9A4-C92D2A88E179Q37844333-78E509B0-D71D-4AA0-BF6E-1510F9A909E6Q38635565-6020C28F-AD16-47B1-9CBB-C8EFD780FB33Q39274066-B4D78686-C28E-44C5-8681-4E618F4CF409Q40114876-E44AD966-9299-4F65-9B96-3A7A4D309BCAQ40431345-7B020552-B0A8-4B74-A17A-6ECAB9126982Q40489535-4355A3F5-B4AF-45CE-932B-88DD99FE92C2Q41354524-D2087937-1B58-4DBA-AE22-08C4D9BBEFDA
P2860
Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Use of synthetic peptides of i ...... icted cytotoxic T lymphocytes.
@ast
Use of synthetic peptides of i ...... icted cytotoxic T lymphocytes.
@en
type
label
Use of synthetic peptides of i ...... icted cytotoxic T lymphocytes.
@ast
Use of synthetic peptides of i ...... icted cytotoxic T lymphocytes.
@en
prefLabel
Use of synthetic peptides of i ...... icted cytotoxic T lymphocytes.
@ast
Use of synthetic peptides of i ...... icted cytotoxic T lymphocytes.
@en
P2093
P2860
P356
P1476
Use of synthetic peptides of i ...... icted cytotoxic T lymphocytes.
@en
P2093
P2860
P304
P356
10.1084/JEM.165.6.1508
P407
P577
1987-06-01T00:00:00Z